Arlington, MA, United States of America

Fernando Padilla

This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Black Diamond Therapeutics, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fernando Padilla. Retrieved from https://idiyas.com/inventor/fernando-padilla-oxh3h925

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Fernando Padilla

Introduction

Fernando Padilla is an accomplished inventor based in Arlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Fernando Padilla holds 1 patent for his work on alkynyl quinazoline compounds. The patent details compounds of Formula (I′) and their pharmaceutically acceptable salts and stereoisomers. It also outlines methods for preparing these compounds, compositions that include them, and their use in preventing or treating abnormal cell growth in mammals, especially humans.

Career Highlights

Fernando Padilla is currently employed at Black Diamond Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new treatments that can significantly impact patient care and outcomes.

Collaborations

Fernando collaborates with Alexander Flohr, contributing to the advancement of their shared goals in the field of drug development.

Conclusion

Fernando Padilla's innovative work in the pharmaceutical industry exemplifies the impact of dedicated inventors on healthcare advancements. His contributions are paving the way for new treatments that could benefit many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…